SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 254 filers reported holding SAGE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $410,000 | +13.9% | 2,900 | +26.1% | 0.14% | +462.5% |
| Q2 2018 | $360,000 | -7.0% | 2,300 | -4.2% | 0.02% | -71.1% |
| Q1 2018 | $387,000 | +23.6% | 2,400 | +26.3% | 0.08% | +27.7% |
| Q4 2017 | $313,000 | -16.3% | 1,900 | -68.3% | 0.06% | -11.0% |
| Q3 2017 | $374,000 | +17.2% | 6,000 | +50.0% | 0.07% | +151.7% |
| Q2 2017 | $319,000 | -79.6% | 4,000 | -81.8% | 0.03% | -84.3% |
| Q1 2017 | $1,564,000 | – | 22,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |